Page 127 - 2020Taiwan Food and Drug Administration Annual Report
P. 127

Table 11c  Amendments for the Chinese Pharmacopoeia and the publication of the
                    T
                           1
                     able 1
                                       “Chinese Pharmacopoeia edition VIII” VXSSOHPHQW
                                           /VNCFS PG   #SJFGJOH PO UIF DPOUFOUT PG UIF BEEJUJPO BOE BNFOENFOU UP UIF “&JHIUI
                            $BUFHPSZ
                                            BSUJDMFT   &EJUJPO PG UIF $IJOFTF 1IBSNBDPQPFJB” TVQQMFNFOUBM BSUJDMFT
                        New Monographs       199    1.The test methods and acceptance criteria for nitrosamine
                                                     impurities in sartan-type active pharmaceutical ingredients were
                         Monographs in       136     added to provide real-time important information.
                         Amendments                 2.The following were addedjApplication of Nuclear Magnetic
                                                     Resonance Spectroscopy, Mid-Infrared Spectroscopy,
                      Active pharmaceutical          Ultraviolet-Visible Spectroscopy, Capsules-Dissolution Testing
                     ingredients with domestic   8   DQG 5HODWHG 4XDOLW\ $WWULEXWHV  0LFURELRORJLFDO ([DPLQDWLRQ RI
                         characteristics             Nonsterile Products: Acceptance Criteria for Pharmaceutical
                                                     Preparations and Substances for Pharmaceutical Use, Analytical
                      New General Chapters   31      Procedures Recombinant Therapeutic Monoclonal Antibodies,
                                                     Validation of Alternative Microbiological Methods, etc.
                       General Chapters in   29     3.Documented the eight active pharmaceutical ingredients
                         Amendments                  such as Potassium Cresolsulfonate, Granisetron, Calcipotriol
                                                     Monohydrate,  Travoprost which were developed and
                             Total           403     manufactured by domestic companies, to promote the
                                                     development of domestic industries.


                   T able 12
                   Table 12c Additional TFDA Analytical Test Methods Form in 2019
                     5FTU NFUIPE                       5FTU NFUIPE OBNF                       4UJQVMBUF
                      DBUFHPSZ                                                               "NFOENFOU
                    Food           0HWKRG RI 7HVW IRU 0DULQH %LRWR[LQV LQ )RRGV   7HVW RI 1HXURWR[LF 6KHOO¿VK  Stipulation
                    promulgated   Poison
                    methods      2.Method of Test for Heavy Metals in Bottled (Packaged) Drinking Water and
                    (25 articles,   Ice Cubes
                    640 items)     0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   6RGLXP Ȗ 3RO\JOXWDPDWH
                                   0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   3RWDVVLXP 6RUEDWH  Amendment
                                   0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   %HQ]RLF $FLG
                                   0HWKRG RI 7HVW IRU $QWLR[LGDQWV LQ )RRGV   0XOWLSOH $QDO\VLV
                                 7.Method of Test for Preservatives in Foods
                                 8.Methods of Test for Specifications of (6S)-5-Methyl-tetrahydrofolic acid,
                                  Glucosamine Salt as Food Raw Material
                                 9.Method of Test for Veterinary Drug Residues in Foods - Test of Multiresidue
                                  $QDO\VLV RI ȕ $JRQLVWV
                                 10.Method of Test for Pesticide Residues in Foods - Multiresidue Analysis (5)
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   6RGLXP %HQ]RDWH
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   6RGLXP (U\WKRUEDWH
                                    0HWKRG RI 7HVW IRU 9HWHULQDU\ 'UXJ 5HVLGXHV LQ )RRGV   7HVW RI )OXQL[LQ
                                  and Tolfenamic acid
                                 14.Method of Test for Veterinary Drug Residues in Foods - Method for
                                  Multiresidue Analysis (2)
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   6RGLXP 3URSLRQDWH
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   '/  0DOLF $FLG
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   6RGLXP '/ 0DODWH
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   *HOODQ *XP
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   &DOFLXP 3URSLRQDWH
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   &DOFLXP &KORULGH
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   $FHVXOIDPH 3RWDVVLXP
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   ' 6RUELWRO
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   /DFWLF $FLG
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   *O\FLQH
                                    0HWKRG RI 7HVW IRU )RRG $GGLWLYH 6SHFL¿FDWLRQV   3URSLRQLF $FLG





                                                                                                         125
   122   123   124   125   126   127   128   129   130   131   132